{"id":2619,"date":"2016-06-24T01:35:14","date_gmt":"2016-06-24T01:35:14","guid":{"rendered":"https:\/\/www.lymphoma.ca\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/"},"modified":"2016-06-24T01:35:14","modified_gmt":"2016-06-24T01:35:14","slug":"lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome","status":"publish","type":"post","link":"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/","title":{"rendered":"L\u2019observation vigilante dans le traitement des patients atteints de lymphome"},"content":{"rendered":"<h2>L\u2019observation vigilante (Watch and Wait) dans le traitement des patients atteints de lymphome : Pourquoi?<\/h2>\n<p>Louise Lacroix, infirmi\u00e8re et aidante naturelle se joint \u00e0 Lymphome Canada pour vous pr\u00e9senter un webinaire sur l\u2019observation vigilante, au cours duquel elle exposera les tenants et aboutissants de cette approche th\u00e9rapeutique. Elle fera aussi un survol des&nbsp; d\u00e9fis auxquels les patients qui y sont soumis doivent faire face et des outils \u00e0 leur disposition.<\/p>\n<p>L\u2019observation vigilante fait partie du protocole de traitement des lymphomes indolents ou \u00e0 croissance lente. Les patients qui se sentent bien, qui n\u2019ont pas de sympt\u00f4mes importants et&nbsp; dont les ganglions ne grossissent pas rapidement et ne menacent pas un organe vital sont souvent avis\u00e9s qu\u2019un suivi p\u00e9riodique r\u00e9gulier est la marche \u00e0 suivre recommand\u00e9e dans leur cas jusqu\u2019\u00e0 ce la maladie exige un traitement.<\/p>\n<p>\u00abQuand on se fait dire qu\u2019on a un lymphome, mais qu\u2019on ne va pas vous traiter tout de suite, c\u2019est un peu comme si on vous disait qu\u2019on ne sait pas comment vous traiter,\u00bb&nbsp; d\u00e9clare Pierre Normandin&nbsp; qui est actuellement en attente vigilante. \u00ab Je me suis senti comme si mon h\u00e9matologue ne voulait pas m\u2019aider.&nbsp;\u00bb<\/p>\n<h4>Ce webinaire est gratuit et&nbsp; ouvert au public.<\/h4>\n<p><strong style=\"font-size: 15px;\">Date :&nbsp;15 ao<span style=\"font-size: 15px;\">\u00fb<\/span><\/strong><strong style=\"font-size: 15px;\">t 2016&nbsp;<\/strong><br \/><strong style=\"font-size: 15px;\">Heure : 19:00 \u00e0 20:00 HAE<\/strong><\/p>\n<p><a class=\"btn\" title=\"Inscrivez-vous\" href=\"https:\/\/attendee.gotowebinar.com\/register\/1493353770039322113\" target=\"_blank\" rel=\"noopener noreferrer\">Inscrivez-vous<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>L\u2019observation vigilante (Watch and Wait) dans le traitement des patients atteints de lymphome : Pourquoi? Louise Lacroix, infirmi\u00e8re et aidante naturelle se joint \u00e0 Lymphome Canada pour vous pr\u00e9senter un&#8230;<\/p>\n","protected":false},"author":1,"featured_media":2617,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12],"tags":[],"class_list":{"0":"post-2619","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-evenements"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>L\u2019observation vigilante dans le traitement des patients atteints de lymphome - Lymphoma Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L\u2019observation vigilante dans le traitement des patients atteints de lymphome - Lymphoma Canada\" \/>\n<meta property=\"og:description\" content=\"L\u2019observation vigilante (Watch and Wait) dans le traitement des patients atteints de lymphome : Pourquoi? Louise Lacroix, infirmi\u00e8re et aidante naturelle se joint \u00e0 Lymphome Canada pour vous pr\u00e9senter un...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/\" \/>\n<meta property=\"og:site_name\" content=\"Lymphoma Canada\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LymphomaCanada\" \/>\n<meta property=\"article:published_time\" content=\"2016-06-24T01:35:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2016\/06\/masthead_ph_rocks.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@lymphomacanada\" \/>\n<meta name=\"twitter:site\" content=\"@lymphomacanada\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4\"},\"headline\":\"L\u2019observation vigilante dans le traitement des patients atteints de lymphome\",\"datePublished\":\"2016-06-24T01:35:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/\"},\"wordCount\":239,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2016\/06\/masthead_ph_rocks.jpg\",\"articleSection\":[\"\u00c9v\u00e9nements\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/\",\"name\":\"L\u2019observation vigilante dans le traitement des patients atteints de lymphome - Lymphoma Canada\",\"isPartOf\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2016\/06\/masthead_ph_rocks.jpg\",\"datePublished\":\"2016-06-24T01:35:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/#primaryimage\",\"url\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2016\/06\/masthead_ph_rocks.jpg\",\"contentUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2016\/06\/masthead_ph_rocks.jpg\",\"width\":700,\"height\":300,\"caption\":\"masthead_ph_rocks\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.lymphoma.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L\u2019observation vigilante dans le traitement des patients atteints de lymphome\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#website\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/\",\"name\":\"Lymphoma Canada\",\"description\":\"Information. Help. Hope.\",\"publisher\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.lymphoma.ca\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\",\"name\":\"Lymphoma Canada\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg\",\"contentUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg\",\"width\":343,\"height\":343,\"caption\":\"Lymphoma Canada\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/LymphomaCanada\",\"https:\/\/x.com\/lymphomacanada\",\"https:\/\/www.linkedin.com\/company\/lymphoma-canada\/\",\"http:\/\/instagram.com\/lymphomacanada\",\"http:\/\/www.youtube.com\/user\/LymphomaTV\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\/\/www.lymphoma.ca\/fr\/author\/erezz_oxmaxp0p\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L\u2019observation vigilante dans le traitement des patients atteints de lymphome - Lymphoma Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/","og_locale":"fr_FR","og_type":"article","og_title":"L\u2019observation vigilante dans le traitement des patients atteints de lymphome - Lymphoma Canada","og_description":"L\u2019observation vigilante (Watch and Wait) dans le traitement des patients atteints de lymphome : Pourquoi? Louise Lacroix, infirmi\u00e8re et aidante naturelle se joint \u00e0 Lymphome Canada pour vous pr\u00e9senter un...","og_url":"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/","og_site_name":"Lymphoma Canada","article_publisher":"https:\/\/www.facebook.com\/LymphomaCanada","article_published_time":"2016-06-24T01:35:14+00:00","og_image":[{"width":700,"height":300,"url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2016\/06\/masthead_ph_rocks.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@lymphomacanada","twitter_site":"@lymphomacanada","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/#article","isPartOf":{"@id":"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/"},"author":{"name":"admin","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4"},"headline":"L\u2019observation vigilante dans le traitement des patients atteints de lymphome","datePublished":"2016-06-24T01:35:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/"},"wordCount":239,"commentCount":0,"publisher":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#organization"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2016\/06\/masthead_ph_rocks.jpg","articleSection":["\u00c9v\u00e9nements"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/","url":"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/","name":"L\u2019observation vigilante dans le traitement des patients atteints de lymphome - Lymphoma Canada","isPartOf":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/#primaryimage"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2016\/06\/masthead_ph_rocks.jpg","datePublished":"2016-06-24T01:35:14+00:00","breadcrumb":{"@id":"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/#primaryimage","url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2016\/06\/masthead_ph_rocks.jpg","contentUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2016\/06\/masthead_ph_rocks.jpg","width":700,"height":300,"caption":"masthead_ph_rocks"},{"@type":"BreadcrumbList","@id":"https:\/\/www.lymphoma.ca\/fr\/lobservation-vigilante-dans-le-traitement-des-patients-atteints-de-lymphome\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.lymphoma.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"L\u2019observation vigilante dans le traitement des patients atteints de lymphome"}]},{"@type":"WebSite","@id":"https:\/\/www.lymphoma.ca\/fr\/#website","url":"https:\/\/www.lymphoma.ca\/fr\/","name":"Lymphoma Canada","description":"Information. Help. Hope.","publisher":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lymphoma.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.lymphoma.ca\/fr\/#organization","name":"Lymphoma Canada","url":"https:\/\/www.lymphoma.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg","contentUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg","width":343,"height":343,"caption":"Lymphoma Canada"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LymphomaCanada","https:\/\/x.com\/lymphomacanada","https:\/\/www.linkedin.com\/company\/lymphoma-canada\/","http:\/\/instagram.com\/lymphomacanada","http:\/\/www.youtube.com\/user\/LymphomaTV"]},{"@type":"Person","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4","name":"admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/www.lymphoma.ca\/fr\/author\/erezz_oxmaxp0p\/"}]}},"_links":{"self":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts\/2619","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/comments?post=2619"}],"version-history":[{"count":0,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts\/2619\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/media\/2617"}],"wp:attachment":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/media?parent=2619"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/categories?post=2619"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/tags?post=2619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}